Roosevelt "Rosey" Gilliam, MD Importance of Conversation, Connection, Family
Rahul Doshi, MD Clinical Risk in Patient Terms
Roosevelt "Rosey" Gilliam, MD Explain SCD in Familiar Terms
Rahul Doshi, MD Illustrating SCD
Education
Talking to Patients
How to Communicate the Risk of SCA to Patients (free Medscape login required)
Support Tools
for Patient Conversations
Sudden Cardiac Arrest Conversation Tool
Sudden Cardiac Arrest: It’s Not a Heart Attack (Resource for Patients)
Back To Reception
Sources >>
Cath Lab
Here you can find a variety of materials about SCD risk post-PCI and post-MI. Download SCD risk screening tools, review relevant clinical studies or learn more about SCD risk assessment with interactive patient case studies.
Click to enter the Cath Lab to start exploring the wealth of evidence about SCD Risk
1
Halkin, A et al. Prediction of Mortality After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: CADILLAC Risk Score. JACC 2005;45:1397–1405.
2
Adabag AS et al. Sudden Death After Myocardial Infarction. JAMA 2008;300:2022–2029.
3
Solomon SD et al. Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both. NEJM 2005;352:2581–2588.
4
Zishiri ET et al. Early Risk of Mortality after Coronary Artery Revascularization in Patients with Left Ventricular Dysfunction and Potential Role of the Wearable Cardioverter Defibrillator. Circulation: Arrhythmia and Electrophysiology.2013;6: 117–128.
5
Weintraub et al. Prediction of Long-Term Mortality After Percutaneous Coronary Intervention in Older Adults: Results From the National Cardiovascular Data Registry. Circulation: 2012;125:1501–1510.
7
Al-Khatib SM et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. J Am Coll Cardiol 2017, doi: 10.1016/j.jack.2017.10.054.
8
Olgin JE, Pletcher MJ, Vittinghoff E, et al. Wearable Cardioverter-Defibrillator after Myocardial Infarction. N Engl J Med. 2018;379(13):1205–1215.
50-60% of mortality during post-PCI/post-MI recovery is due to SCD (EF≤35%)6,8
Despite PCI and GDMT, 1 in 20 post-MI (EF<35%) patients die in the first 90 days8
Following an MI, risk of SCD is highest in the first 90 days3
Use this infographic to support discussion with your patients about their SCA risk